Controlled Substance Manufacturing
ARTICLES
-
Bridging Studies For Producer Cell Line Adoption: Regulatory And Development Perspectives
Explore how analytical comparability, risk assessment, and bridging strategies can support a smooth and compliant platform transition.
-
Strategic CDMO Partnerships Begin By Unraveling The Complexities
Selecting the right CDMO is critical for pharmaceutical sponsors. To avoid pitfalls, sponsors should evaluate a CDMO's capacity, technical capabilities, quality metrics (like CAPA effectiveness and deviation times), financial stability, and talent retention. Establishing strong communication, supply chain transparency, and routine quality audits also helps ensure a successful, long-term partnership.
SUPPLIER PROFILES
-
Novasep
Novasep brings innovative solutions to complex challenges within the life science industries for the production of synthetic molecules and biomolecules.
-
Paragon BioServices, Inc.
Founded in 1990, Paragon Bioservices is a CMC Center of Excellence delivering research, development and cGMP manufacturing services to pharmaceutical companies, biotechnology companies and federal agencies
-
PYRAMID Laboratories, Inc.
PYRAMID Laboratories, Inc. (PYRAMID), established in 1988, is located in Southern California, USA. Our facilities are housed in three (3) buildings covering approximately 70,000 sq. ft.
-
Recipharm AB
Recipharm is one of Europe’s leading pharmaceutical Contract Development and Manufacturing Organisations (CDMO).
-
Roche Custom Biotech
With over 50 years of biotechnology experience, a worldwide presence, and strong customer orientation, Roche Custom Biotech is uniquely positioned to supply the Diagnostics, Pharma, and Biotech industry with products and services, customized to your quality and regulatory needs.
SERVICES
-
Wet Nanomilling And Vial Filling
Nanomilling revolutionizes drug delivery by reducing particle size to enhance solubility, bioavailability, and therapeutic efficacy, addressing the challenges of poorly water-soluble APIs.
-
Solutions For Injectables And Parenteral Formulations
Sterility is key for high-risk applications such as injectables, parenteral formulations, ophthalmic and peritoneal dialysis solutions, and many more.
NEWS
-
Stevanato Group Appoints Riccardo Butta As President, Americas2/2/2022
The appointment of a dedicated executive to lead the Company’s long-term strategy in the Americas is indicative of the growing regional demand trends and the Company’s commitment to broaden its footprint, accelerate its market penetration and improve proximity to its customers in this important region.